Additional information
| Water Retention | None |
|---|---|
| Hepatotoxicity | Low |
| Lab Test | Not specific |
| Strength | 200 mg |
| Also known as | EIDD-2801 |
| Blood pressure | No significant effects |
| Trade name | Lagevrio |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | ОІ-D-N4-hydroxycytidine |
| Formula | C13H19N3O7 |
| Substance class | Antiviral medication |
| Main action | Induces viral mutagenesis |
| Half-life | Approximately 7 hours |
| Dosage (medical) | 800 mg twice daily for 5 days |
| Dosage (sports) | Not applicable |
| Effects | Reduces the risk of hospitalization or death in COVID-19 patients |
| Side effects | Diarrhea, nausea, dizziness |
| Use in sports | None |
| Manufacturer | Healing Pharma |
Fostimon (Merional) 75 (HMG) IBSA
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
Prograf 5mg Astellas Pharma
DELETE - Micardis 80 mg Boehringer Ingelheim
FACTIVE 320 mg Abdi Ibragim
Zyban Glaxosmithkline
FUCIDIN 500 mg Abdi Ibragim
Fostimon (Merional) 150 IU HMG IBSA
Norvacs 10 mg Pfizer
Rovamycine 3.000.000 iu Eczacibasi
AVELOX 400 Bayer
Eurigil 5000 Euro-Pharmacies
NOLVADEX (TAMOXIFEN) AstraZeneca
BIOSYNERGY RECOVERY3 PEPTIDE BLEND LIFETECH LABS
Altamofen Pharmaceutical 

Reviews
There are no reviews yet.